Considering all of the data and their limitations, questions still remain regarding the optimal treatment of COPD exacerbations ... reasonable to recommend oral corticosteroids when patient ...

patients with Anthonisen criteria I and II should be prescribed antibiotics and systemic corticosteroids. Follow up for patients with acute exacerbation of chronic obstructive pulmonary disease ...

Sanofi today shared new progress from its mid- to late-stage respiratory pipeline, including preliminary phase 2 results for amlitelimab in adults with moderate-to-severe asthma.

Trelegy – based on corticosteroid fluticasone furoate, LAMA umeclidinium and LABA vilanterol and approved in 2017 – is central to GSK’s efforts to replace its COPD blockbuster Seretide ...

Verona Pharma has agreed a new $400 million debt facility with Oxford Finance and Hercules Capital designed to help the company navigate the possible approval and launch of ensifentrine, its ...

Scientifically formulated with mullein, peppermint oil, oregano, and eucalyptus, BREATHE Drops deliver powerful natural lung ...

Long-term ICS use in COPD increases risks of severe health conditions like Type 2 diabetes and fractures. Read more!

Discover what bronchial spasms are, including their causes, symptoms, and effective remedies. Learn how to manage and prevent ...

Discover the telltale signs that distinguish allergic bronchitis from regular allergies, and effective treatments when this ...

29 Based on survey responses, the COPD severity score is comprised of five overall aspects of COPD severity: respiratory symptoms, systemic corticosteroid use, other COPD medication use, previous ...